India’s drug regulator CDSCO has tightened rules for drug safety reporting. Pharma firms must file safety reports starting from the actual launch date of new drugs rather than the approval date. The regulator says this will better capture real-world safety signals. It also brings all forms and uses of a new drug under one consolidated safety report.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
